{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:05:32Z","timestamp":1785708332582,"version":"3.56.0"},"reference-count":21,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,22]]},"DOI":"10.20945\/2359-4292-2023-0211","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T15:05:09Z","timestamp":1711465509000},"source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of screening practices for primary hyperaldosteronism by specialists and general practitioners: an observational, cross-sectional study"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7177-0446","authenticated-orcid":false,"given":"Giselle Fernandes","family":"Taboada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-7458","authenticated-orcid":false,"given":"Aline Barbosa","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-3985","authenticated-orcid":false,"suffix":"Neto","given":"Leonardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"1","key":"key20240326103736_B1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","unstructured":"1 Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41-50. doi: 10.1016\/S2213-8587(17)30319-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"key20240326103736_B2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","unstructured":"2 Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39(6):1057-88. doi: 10.1210\/er.2018-00139.","journal-title":"Endocr Rev"},{"issue":"1","key":"key20240326103736_B3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","unstructured":"3 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(1):51-9. doi: 10.1016\/S2213-8587(17)30367-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"key20240326103736_B4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: a cohort study","volume":"75","author":"Jaffe","year":"2020","unstructured":"4 Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening rates for primary aldosteronism in resistant hypertension: a cohort study. Hypertension. 2020;75(3):650-9. doi: 10.1161\/HYPERTENSIONAHA.119.14359.","journal-title":"Hypertension"},{"issue":"1","key":"key20240326103736_B5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","article-title":"Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives","volume":"165","author":"Ruhle","year":"2019","unstructured":"5 Ruhle BC, White MG, Alsafran S, Kaplan EL, Angelos P, Grogan RH. Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives. Surgery. 2019;165(1):221-7. doi: 10.1016\/j.surg.2018.05.085","journal-title":"Surgery"},{"issue":"6","key":"key20240326103736_B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/a-1156-9926","article-title":"Progress in primary aldosteronism 2019: new players on the block?","volume":"52","author":"Reincke","year":"2020","unstructured":"6 Reincke M, Beuschlein F, Williams TA. Progress in primary aldosteronism 2019: new players on the block? Horm Metab Res. 2020;52(6):345-6. doi: 10.1055\/a-1156-9926.","journal-title":"Horm Metab Res"},{"issue":"11","key":"key20240326103736_B7","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","unstructured":"7 Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens. 2016;34(11):2253-7. doi: 10.1097\/HJH.0000000000001088.","journal-title":"J Hypertens"},{"issue":"3","key":"key20240326103736_B8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans: A Retrospective Cohort Study","volume":"174","author":"Cohen","year":"2021","unstructured":"8 Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans: A Retrospective Cohort Study. Ann Intern Med. 2021;174(3):289-97. doi: 10.7326\/M20-4873.","journal-title":"Ann Intern Med"},{"issue":"5","key":"key20240326103736_B9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","unstructured":"9 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889-916. doi: 10.1210\/jc.2015-4061.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20240326103736_B10","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya","year":"2020","unstructured":"10 Vaidya A, Carey RM. Evolution of the primary aldosteronism syndrome: updating the approach. J Clin Endocrinol Metab. 2020;105(12):3771-83. doi:10.1210\/clinem\/dgaa606.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20240326103736_B11","first-page":"661","article-title":"Primary aldosteronism","volume":"45","author":"Conn","year":"1955","unstructured":"11 Conn JW. Primary aldosteronism. J Lab Clin Med. 1955;45(4):661-4.","journal-title":"J Lab Clin Med"},{"issue":"11","key":"key20240326103736_B12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","unstructured":"12 Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al.; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293-300. doi: 10.1016\/j.jacc.2006.07.059.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20240326103736_B13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","unstructured":"13 Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045-50. doi: 10.1210\/jc.2003-031337.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20240326103736_B14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","unstructured":"14 Hundemer GL, Imsirovic H, Vaidya A, Yozamp N, Goupil R, Madore F, et al. Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study. Hypertension. 2022;79(1):178-86. doi:10.1161\/HYPERTENSIONAHA.121.18118.","journal-title":"Hypertension"},{"issue":"5","key":"key20240326103736_B15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","unstructured":"15 Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab. 2014;99(5):1593-8. doi: 10.1210\/jc.2013-2180.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20240326103736_B16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","unstructured":"16 Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285(2):126-48. doi: 10.1111\/joim.12831.","journal-title":"J Intern Med"},{"key":"key20240326103736_B17","article-title":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE)","year":"2022","unstructured":"17 Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). Censo 2022. Available from: https:\/\/censo2022.ibge.gov.br\/panorama\/.","journal-title":"Censo"},{"issue":"3","key":"key20240326103736_B18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.36660\/abc.20201238","article-title":"Brazilian Guidelines of Hypertension \u2013 2020","volume":"116","author":"Barroso","year":"2021","unstructured":"18 Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brand\u00e3o AA, Feitosa ADM, et al. Brazilian Guidelines of Hypertension \u2013 2020. Arq Bras Cardiol. 2021;116(3):516-658. doi: 10.36660\/abc.20201238.","journal-title":"Arq Bras Cardiol"},{"issue":"7","key":"key20240326103736_B19","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis","volume":"101","author":"K\u00e4yser","year":"2016","unstructured":"19 K\u00e4yser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Bakx JC, van der Wel MC, et al. Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016;101(7):2826-35. https:\/\/doi.org\/10.1210\/jc.2016-1472","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20240326103736_B20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","unstructured":"20 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al.; Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J. 2011;58(9):711-21. doi: 10.1507\/endocrj.ej11-0133.","journal-title":"Endocr J"},{"issue":"14","key":"key20240326103736_B21","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jacc.2017.02.041","article-title":"The time has come for systematic screening for primary aldosteronism in all hypertensives","volume":"69","author":"Maiolino","year":"2017","unstructured":"21 Maiolino G, Cal\u00f2 LA, Rossi GP. The time has come for systematic screening for primary aldosteronism in all hypertensives. J Am Coll Cardiol. 2017;69(14):1821-23. doi: 10.1016\/j.jacc.2017.02.041.","journal-title":"J Am Coll Cardiol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T15:05:24Z","timestamp":1711465524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/evaluation-of-screening-practices-for-primary-hyperaldosteronism-by-specialists-and-general-practitioners-an-observational-cross-sectional-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":21,"alternative-id":["10.20945\/2359-4292-2023-0211"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0211","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230211"}}